INSIGHTS ON DRUG DEVELOPMENT

• The History Of Chemical Nomenclature And ACD/Name

  Modern chemical naming requires algorithmic precision to match evolving standards and new compound classes. Up-to-date nomenclature ensures regulatory compliance and seamless workflow integration.

• Robust Database Characterizes And Optimizes Product Development

  Integrating material characterization data with process parameters accelerates drug development, reduces empirical testing, and strengthens regulatory compliance.

• Streamlining Early Drug Development: Efficient Synthesis Of Highly Potent Compounds

  Discover how risk‑based, phase‑appropriate synthesis enables safe, efficient production of highly potent compounds while balancing speed, worker safety, and regulatory readiness in early development.

• Streamline Drug Development With A Lab Informatics Platform

  Learn how a tiered approach to ADME-Tox studies can help researchers navigate early-stage preclinical research and mitigate the risk of costly failures in drug development.

• The Next Generation Of Thermal Stability Testing For Biologic Drugs

  10/3/2024

  Achieving precise measurements in a high-throughput setting can be challenging without disrupting workflows or deadlines. Learn about a new tool for rapid biotherapeutic thermal stability characterization.

• Biophysical Tools For Biotherapeutic Development

  6/26/2025

  Discover essential analytical techniques in biotherapeutics development, as well as explore ITC, DSC, and Rheology—powerful tools for understanding formulation, stability, and efficacy in drug development.

• UPLC-MS/MS Determination Of GLP-1 Analogue

  7/17/2025

  Discover a robust, evaporation-free method for analyzing liraglutide in human plasma using LC-MS/MS to ensure high sensitivity, reproducibility, and improved analyte recovery.

• The Body As A Bioreactor – Delivering The Vision

  8/8/2026

  Making the body a bioreactor requires precise delivery to selected cells. See how lipid nanoparticles, manufacturing science, and biology are converging to overcome biological barriers and improve the targeting of advanced therapies.

• Studying The Spatial Architecture Of Glioblastoma

  3/24/2025

  Explore how intra-tumor heterogeneity (ITH) impacts cancer progression and therapy resistance with advanced imaging platforms and custom antibody panels to reveal the spatial architecture of glioblastoma (GBM).